Skip to main content
Top
Gepubliceerd in:

01-06-2015 | Original Paper

Autism Spectrum Disorder Profile in Neurofibromatosis Type I

Auteurs: Shruti Garg, Ellen Plasschaert, Mie-Jef Descheemaeker, Susan Huson, Martine Borghgraef, Annick Vogels, D. Gareth Evans, Eric Legius, Jonathan Green

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 6/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Neurofibromatosis Type 1 (NF1) is a common autosomal dominant single-gene disorder, in which the co-occurrence of autism spectrum disorder (ASD) has attracted considerable research interest recently with prevalence estimates of 21–40 %. However, detailed characterization of the ASD behavioral phenotype in NF1 is still lacking. This study characterized the phenotypic profile of ASD symptomatology presenting in 4–16 year old children with NF1 (n = 36) using evidence from parent-rated Social Responsiveness Scale and researcher autism diagnostic observation Scale-2. Compared to IQ-matched reference groups of children with autism and ASD, the NF1 profile shows overall similarity but improved eye contact, less repetitive behaviors and better language skills.
Literatuur
go back to reference Abrahams, B. S., & Geschwind, D. H. (2008). Advances in autism genetics: On the threshold of a new neurobiology [Research support, N.I.H., extramural research support, Non-U.S. gov’t review]. Nature Reviews Genetics, 9(5), 341–355. doi:10.1038/nrg2346.CrossRefPubMedCentralPubMed Abrahams, B. S., & Geschwind, D. H. (2008). Advances in autism genetics: On the threshold of a new neurobiology [Research support, N.I.H., extramural research support, Non-U.S. gov’t review]. Nature Reviews Genetics, 9(5), 341–355. doi:10.​1038/​nrg2346.CrossRefPubMedCentralPubMed
go back to reference Acosta, M., Kardel, P., Walsh, K., Rosenbaum, K., Gioia, G., & Packer, R. (2011). Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: Phase 1 study. Pediatric Neurology, 45, 241–245.CrossRefPubMed Acosta, M., Kardel, P., Walsh, K., Rosenbaum, K., Gioia, G., & Packer, R. (2011). Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: Phase 1 study. Pediatric Neurology, 45, 241–245.CrossRefPubMed
go back to reference American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.CrossRef American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.CrossRef
go back to reference Baird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, D., et al. (2006). Prevalence of disorders of the autism spectrum in a population cohort of children in south thames: The special needs and autism project (SNAP). The Lancet, 15(9531), 210–215.CrossRef Baird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, D., et al. (2006). Prevalence of disorders of the autism spectrum in a population cohort of children in south thames: The special needs and autism project (SNAP). The Lancet, 15(9531), 210–215.CrossRef
go back to reference Barton, B., & North, K. (2004). Social skills of children with neurofibromatosis type 1. Developmental Medicine and Child Neurology, 46, 553–563.CrossRefPubMed Barton, B., & North, K. (2004). Social skills of children with neurofibromatosis type 1. Developmental Medicine and Child Neurology, 46, 553–563.CrossRefPubMed
go back to reference Constantino, J., Davis, S., Todd, R., Schindler, M.K., Gross, M., Brophy, S., et al. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders, 33(4), 427–433. Constantino, J., Davis, S., Todd, R., Schindler, M.K., Gross, M., Brophy, S., et al. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders, 33(4), 427–433.
go back to reference Coude, F., Mignot, C., Lyonnet, S., & Munnich, A. (2007). Early grade repetition and inattention associated with neurofibromatosis type 1. Journal of Attention Disorders, 11, 101–105. Coude, F., Mignot, C., Lyonnet, S., & Munnich, A. (2007). Early grade repetition and inattention associated with neurofibromatosis type 1. Journal of Attention Disorders, 11, 101–105.
go back to reference Costa, R., Federov, N., Kogan, J., Murphy, G., Stern, J., Ohno, M., et al. (2002). Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature, 415, 526–530.CrossRefPubMed Costa, R., Federov, N., Kogan, J., Murphy, G., Stern, J., Ohno, M., et al. (2002). Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature, 415, 526–530.CrossRefPubMed
go back to reference Deardorf MA, Clark DM, & Krantz ID (2005). Cornelia de Lange Syndrome. GeneReviewsTM[Internet]. Seattle (WA): University of Washington, Seattle. Deardorf MA, Clark DM, & Krantz ID (2005). Cornelia de Lange Syndrome. GeneReviewsTM[Internet]. Seattle (WA): University of Washington, Seattle.
go back to reference Evans, D. G., Howard, E., Giblin, C., Clancy, T., Spencer, H., Huson, S. M., et al. (2010). Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. [Research support, Non-U.S. Gov’t]. American Journal of Medical Genetics Part A, 152A(2), 327–332. doi:10.1002/ajmg.a.33139.CrossRefPubMed Evans, D. G., Howard, E., Giblin, C., Clancy, T., Spencer, H., Huson, S. M., et al. (2010). Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service. [Research support, Non-U.S. Gov’t]. American Journal of Medical Genetics Part A, 152A(2), 327–332. doi:10.​1002/​ajmg.​a.​33139.CrossRefPubMed
go back to reference Fombonne, E., du Mazaubrun, C., Cans, C., & Grandjean, H. (1997). Autism and associated medical disorders in a large French epidemiological sample. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1561–1569.PubMed Fombonne, E., du Mazaubrun, C., Cans, C., & Grandjean, H. (1997). Autism and associated medical disorders in a large French epidemiological sample. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1561–1569.PubMed
go back to reference Gillberg, C., & Forsell, C. (1984). Childhood psychosis and neurofibromatosis—more than a coincidence? Journal of Autism and Developmental Disorders, 14(1), 1–8.CrossRefPubMed Gillberg, C., & Forsell, C. (1984). Childhood psychosis and neurofibromatosis—more than a coincidence? Journal of Autism and Developmental Disorders, 14(1), 1–8.CrossRefPubMed
go back to reference Huijbregts, S., Jahja, R., De Sonneville, L., De Breij, S., & Swaab-Barneveld, H. (2010). Social information processing in children and adolescents with neurofibromatosis type 1. Developmental Medicine and Child Neurology, 52(7), 620–625.CrossRefPubMed Huijbregts, S., Jahja, R., De Sonneville, L., De Breij, S., & Swaab-Barneveld, H. (2010). Social information processing in children and adolescents with neurofibromatosis type 1. Developmental Medicine and Child Neurology, 52(7), 620–625.CrossRefPubMed
go back to reference Krab, L., de Goede-Bolder, A., Aarsen, F., Pluijm, S., Bouman, M., van der Geest, J., et al. (2008). Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: A randomized controlled trial. JAMA, 300(3), 287–294.CrossRefPubMedCentralPubMed Krab, L., de Goede-Bolder, A., Aarsen, F., Pluijm, S., Bouman, M., van der Geest, J., et al. (2008). Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: A randomized controlled trial. JAMA, 300(3), 287–294.CrossRefPubMedCentralPubMed
go back to reference Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (2012). Autism diagnostic observation schedule, second edition (ADOS-2) manual (part I): Modules 1-4. Torrance, CA: Western Psychological Services. Lord, C., Rutter, M., DiLavore, P. C., Risi, S., Gotham, K., & Bishop, S. L. (2012). Autism diagnostic observation schedule, second edition (ADOS-2) manual (part I): Modules 1-4. Torrance, CA: Western Psychological Services.
go back to reference Mautner, V. F., Kluwe, L., Friedrich, R. E., Roehl, A. C., Bammert, S., Högel, J., et al. (2010). Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. Journal of Medical Genetics, 47(9), 623–630.CrossRefPubMed Mautner, V. F., Kluwe, L., Friedrich, R. E., Roehl, A. C., Bammert, S., Högel, J., et al. (2010). Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. Journal of Medical Genetics, 47(9), 623–630.CrossRefPubMed
go back to reference Mouridsen, S., Andersen, L., Sörensen, S., Rich, B., & Isager, T. (1992). Neurofibromatosis in infantile autism and other types of childhood psychoses. Acta Paedopsychiatrica: International Journal of Child & Adolescent Psychiatry, 55, 15–18. Mouridsen, S., Andersen, L., Sörensen, S., Rich, B., & Isager, T. (1992). Neurofibromatosis in infantile autism and other types of childhood psychoses. Acta Paedopsychiatrica: International Journal of Child & Adolescent Psychiatry, 55, 15–18.
go back to reference National Institutes of Health Consensus Development Conference. (1988). Neurofibromatosis conference statement. Archives of Neurology, 45, 575–578.CrossRef National Institutes of Health Consensus Development Conference. (1988). Neurofibromatosis conference statement. Archives of Neurology, 45, 575–578.CrossRef
go back to reference Noll, R., Reiter-Purtill, J., Moore, B., Schorry, E., Lovell, A., Vannatta, K., et al. (2007). Social, emotional, and behavioral functioning of children with NF1. American Journal of Medical Genetics Part A, 143A, 2261–2273.CrossRefPubMed Noll, R., Reiter-Purtill, J., Moore, B., Schorry, E., Lovell, A., Vannatta, K., et al. (2007). Social, emotional, and behavioral functioning of children with NF1. American Journal of Medical Genetics Part A, 143A, 2261–2273.CrossRefPubMed
go back to reference Oliver, C., Berg, K., Moss, J., Arron, K., & Burbidge, C. (2011). Delineation of behavioral phenotypes in genetic syndromes: Characteristics of autism spectrum disorder, affect and hyperactivity. Journal of Autism and Developmental Disorders, 41(8), 1019–1032. doi:10.1007/s10803-010-1125-5.CrossRefPubMed Oliver, C., Berg, K., Moss, J., Arron, K., & Burbidge, C. (2011). Delineation of behavioral phenotypes in genetic syndromes: Characteristics of autism spectrum disorder, affect and hyperactivity. Journal of Autism and Developmental Disorders, 41(8), 1019–1032. doi:10.​1007/​s10803-010-1125-5.CrossRefPubMed
go back to reference Plasschaert, E., Descheemaeker, M. J., Van Eylen, L., Noens, I., Steyaert, J., & Legius, E. (2014). Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. doi:10.1002/ajmg.b.32280. Plasschaert, E., Descheemaeker, M. J., Van Eylen, L., Noens, I., Steyaert, J., & Legius, E. (2014). Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. doi:10.​1002/​ajmg.​b.​32280.
go back to reference Rogers, S. J., Wehner, D. E., & Hagerman, R. (2001). The behavioral phenotype in fragile X: Symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. Journal of Developmental and Behavioral Pediatrics, 22(6), 409–417.CrossRefPubMed Rogers, S. J., Wehner, D. E., & Hagerman, R. (2001). The behavioral phenotype in fragile X: Symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. Journal of Developmental and Behavioral Pediatrics, 22(6), 409–417.CrossRefPubMed
go back to reference Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of American Academy of Child & Adolescent Psychiatry, 47(8), 921–929.CrossRef Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of American Academy of Child & Adolescent Psychiatry, 47(8), 921–929.CrossRef
go back to reference van der Vaart, T., Plasschaert, E., Rietman, A. B., Renard, M., Oostenbrink, R., Vogels, A., et al. (2013). Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): A randomised, placebo-controlled trial. The Lancet Neurology, 12(11), 1076–1083. doi:10.1016/S1474-4422(13)70227-8S1474-4422(13)70227-8.CrossRefPubMed van der Vaart, T., Plasschaert, E., Rietman, A. B., Renard, M., Oostenbrink, R., Vogels, A., et al. (2013). Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): A randomised, placebo-controlled trial. The Lancet Neurology, 12(11), 1076–1083. doi:10.​1016/​S1474-4422(13)70227-8S1474-4422(13)70227-8.CrossRefPubMed
go back to reference Walsh, K. S., Velez, J. I., Kardel, P. G., Imas, D. M., Muenke, M., Packer, R. J., et al. (2013). Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. [Research Support, N.I.H., Extramural]. Developmental Medicine and Child Neurology, 55(2), 131–138. doi:10.1111/dmcn.12038.CrossRefPubMed Walsh, K. S., Velez, J. I., Kardel, P. G., Imas, D. M., Muenke, M., Packer, R. J., et al. (2013). Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. [Research Support, N.I.H., Extramural]. Developmental Medicine and Child Neurology, 55(2), 131–138. doi:10.​1111/​dmcn.​12038.CrossRefPubMed
go back to reference Wechsler, D. (2004). The Wechsler intelligence scale for children—fourth edition. London: Pearson Assessment. Wechsler, D. (2004). The Wechsler intelligence scale for children—fourth edition. London: Pearson Assessment.
Metagegevens
Titel
Autism Spectrum Disorder Profile in Neurofibromatosis Type I
Auteurs
Shruti Garg
Ellen Plasschaert
Mie-Jef Descheemaeker
Susan Huson
Martine Borghgraef
Annick Vogels
D. Gareth Evans
Eric Legius
Jonathan Green
Publicatiedatum
01-06-2015
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 6/2015
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-014-2321-5